Fragment-Based Drug Discovery

Fragment-Based Drug Discovery
Author: Steven Howard
Publisher: Royal Society of Chemistry
Total Pages: 314
Release: 2015-06-17
Genre: Medical
ISBN: 1782625658

Fragment-based drug discovery is a rapidly evolving area of research, which has recently seen new applications in areas such as epigenetics, GPCRs and the identification of novel allosteric binding pockets. The first fragment-derived drug was recently approved for the treatment of melanoma. It is hoped that this approval is just the beginning of the many drugs yet to be discovered using this fascinating technique. This book is written from a Chemist's perspective and comprehensively assesses the impact of fragment-based drug discovery on a wide variety of areas of medicinal chemistry. It will prove to be an invaluable resource for medicinal chemists working in academia and industry, as well as anyone interested in novel drug discovery techniques.

Design and Synthesis of (3D) Cyclobutane Fragments for Use in Fragment-based Drug Discovery

Design and Synthesis of (3D) Cyclobutane Fragments for Use in Fragment-based Drug Discovery
Author:
Publisher:
Total Pages: 0
Release: 2023
Genre:
ISBN:

Fragment-based drug discovery (FBDD) has grown into a well-established approach in the pursuit of new therapeutics, and has a growing need for unique screening libraries. Historically, fragment libraries have largely comprised planar compounds with a two-dimensional (2D) shape. It remains to be seen if three-dimensional (3D) fragments could also offer benefits e.g. improved solubility, selectivity, and fragment elaboration. Substantial interest has been placed on the design and synthesis of 3D fragments, and methodology which allows access to or diversification of such scaffolds. To this end, a review providing an overview of 25 synthetic (3D) fragments libraries from recent literature was conducted, providing a comprehensive summary of different collections according to their calculated physicochemical properties and 3D descriptors – fraction sp3 (Fsp3), plane of best fit (PBF) scores and principal moment of inertia (PMI) plots – allowing for fair comparison between different libraries. Initially arising as an intermediate in fragment synthesis, the bromo-cyclobutenaminone scaffold was identified as a novel covalent warhead against a key antibacterial target: UDP-N-acetylglucosamine enolpyruvyl transferase (MurA). Screening a small library of cyclobutenone derivatives led to the identification of bromo-cyclobutenaminones as new covalent inhibitors or MurA. The electrophilic reactivity and cysteine specificity were determined in a glutathione (GSH) and an oligopeptide assay, respectively. Investigating the structure-activity relationship for MurA suggested a crucial role for the bromine atom. In addition, MS/MS experiments proved the covalent labelling of MurA at Cys115 and the observed loss of the bromine atom suggests a net nucleophilic substitution as the covalent reaction. This new set of compounds might be considered as a viable chemical starting point for the discovery of new MurA inhibitors. To address the overpopulation of 2D moieties in fragment libraries, the cyclobutane ring was identified as an underrepresented yet attractive motif which could offer benefits in terms of generating 3D fragments. We report the design and synthesis of a focused set 33 cyclobutane fragments, via a key 3-azido-cyclobutanone building block, giving potential access to a range of functional groups with accessible growth vectors. In this work, the library was designed using Principal Component Analysis (PCA) within Molecular Operating Environment (MOE) and was guided by an expanded version of the rule of three (RO3), followed by Principal Moment of Inertia (PMI) analysis to achieve both chemical diversity and high 3D character. The synthesised cyclobutanol fragments comprised three functionalities at the 3-amino handle: secondary amines, amides, and sulfonamides. Both cis and trans ring isomers of library members were generated, as a means of maximising the shape diversity obtained, while limiting molecular complexity through abrogating enantiomers. Property analyses were conducted, with the cyclobutane library faring favourably against existing synthetic 3D fragment libraries in terms of shape and physicochemical properties. The utility of the cyclobutane fragment library, optimistically, remains to be seen in upcoming screening cascades. Indeed, a mixture of 2D and 3D fragment with a variety of molecular shapes and properties is likely necessary to maximise the chances of finding quality hits for screening cascades.

Diversity Oriented Synthesis

Diversity Oriented Synthesis
Author: Andrea Basso
Publisher: Frontiers Media SA
Total Pages: 150
Release: 2019-03-22
Genre:
ISBN: 2889457885

Has the concept of Diversity Oriented Synthesis remained unchanged over these two decades, or do we observe improvements or deviations from the original guidelines drawn by the pioneers? The aim of this Research Topic is to collect contributions on the state-of-the-art and progress of Diversity Oriented Synthesis, and to foresee its shape in the next decade.

Fragment-based Drug Discovery

Fragment-based Drug Discovery
Author: Daniel A. Erlanson
Publisher: John Wiley & Sons
Total Pages: 524
Release: 2016-02-23
Genre: Medical
ISBN: 352733775X

From its origins as a niche technique more than 15 years ago, fragment-based approaches have become a major tool for drug and ligand discovery, often yielding results where other methods have failed. Written by the pioneers in the field, this book provides a comprehensive overview of current methods and applications of fragment-based discovery, as well as an outlook on where the field is headed. The first part discusses basic considerations of when to use fragment-based methods, how to select targets, and how to build libraries in the chemical fragment space. The second part describes established, novel and emerging methods for fragment screening, including empirical as well as computational approaches. Special cases of fragment-based screening, e. g. for complex target systems and for covalent inhibitors are also discussed. The third part presents several case studies from recent and on-going drug discovery projects for a variety of target classes, from kinases and phosphatases to targeting protein-protein interaction and epigenetic targets.

Combinatorial Library Design and Evaluation

Combinatorial Library Design and Evaluation
Author: Arup Ghose
Publisher: CRC Press
Total Pages: 655
Release: 2001-06-26
Genre: Medical
ISBN: 1482270765

This text traces developments in rational drug discovery and combinatorial library design with contributions from 50 leading scientists in academia and industry who offer coverage of basic principles, design strategies, methodologies, software tools and algorithms, and applications. It outlines the fundamentals of pharmacophore modelling and 3D Qua

Fragment-based Approaches in Drug Discovery

Fragment-based Approaches in Drug Discovery
Author: Wolfgang Jahnke
Publisher: John Wiley & Sons
Total Pages: 391
Release: 2006-12-13
Genre: Science
ISBN: 3527608605

This first systematic summary of the impact of fragment-based approaches on the drug development process provides essential information that was previously unavailable. Adopting a practice-oriented approach, this represents a book by professionals for professionals, tailor-made for drug developers in the pharma and biotech sector who need to keep up-to-date on the latest technologies and strategies in pharmaceutical ligand design. The book is clearly divided into three sections on ligand design, spectroscopic techniques, and screening and drug discovery, backed by numerous case studies.

De novo Molecular Design

De novo Molecular Design
Author: Gisbert Schneider
Publisher: Wiley-VCH
Total Pages: 0
Release: 2013-12-23
Genre: Medical
ISBN: 9783527334612

Systematically examining current methods and strategies, this ready reference covers a wide range of molecular structures, from organic-chemical drugs to peptides, Proteins and nucleic acids, in line with emerging new drug classes derived from biomacromolecules. A leader in the field and one of the pioneers of this young discipline has assembled here the most prominent experts from across the world to provide first-hand knowledge. While most of their methods and examples come from the area of pharmaceutical discovery and development, the approaches are equally applicable for chemical probes and diagnostics, pesticides, and any other molecule designed to interact with a biological system. Numerous images and screenshots illustrate the many examples and method descriptions. With its broad and balanced coverage, this will be the firststop resource not only for medicinal chemists, biochemists and biotechnologists, but equally for bioinformaticians and molecular designers for many years to come. From the content: * Reaction-driven de novo design * Adaptive methods in molecular design * Design of ligands against multitarget profiles * Free energy methods in ligand design * Fragment-based de novo design * Automated design of focused and target family-oriented compound libraries * Molecular de novo design by nature-inspired computing * 3D QSAR approaches to de novo drug design * Bioisosteres in de novo design * De novo design of peptides, proteins and nucleic acid structures, including RNA aptamers and many more.